Hormonal Intrauterine Devices (IUDs) Market Size And Forecast 2026–2030: Trends Driving Industry Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Hormonal Intrauterine Devices (IUDs) Market Size And Revenue Outlook Through 2030
The market size for hormonal intrauterine devices (IUDs) has experienced substantial growth in recent years. This market is projected to expand from $2.87 billion in 2025 to $3.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. In the past, this expansion has been fueled by factors including greater public awareness of family planning alternatives, the broadening of women’s reproductive healthcare initiatives, a growing preference for enduring contraception, the accessibility of hormone-based devices, and backing from public health programs.
The market for hormonal intrauterine devices (IUDs) is projected to experience swift expansion over the coming years. This market is anticipated to reach $4.74 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Several factors are driving this growth during the forecast period, including a heightened demand for non-surgical contraceptive options, a greater emphasis on menstrual health management, broader access in developing markets, increased investments in women’s health technologies, and continuous innovation in hormone delivery systems. Key trends for the forecast period encompass the rising adoption of low-dose hormonal IUDs, increasing preference for long-acting reversible contraceptives, a growing inclination towards frameless device designs, the broadening of therapeutic IUD applications, and a stronger emphasis on patient comfort and safety.
Get A Free Sample Report With In-Depth Market Insights:
Hormonal Intrauterine Devices (IUDs) Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing prevalence of unwanted pregnancies is anticipated to drive the expansion of the hormonal intrauterine devices market. Unwanted pregnancies are those not deliberately planned or wished for at the moment of conception. These can arise from multiple factors, including the ineffectiveness of contraceptive methods, insufficient access to birth control, improper use of contraception, or experiences of sexual violence. Limited availability of reliable contraception heightens the risk of unwanted pregnancies by lessening individuals’ autonomy over their reproductive choices. Hormonal IUDs are exceptionally effective at preventing pregnancy, with a failure rate under 1%. They deliver long-term protection, typically ranging from 3 to 7 years depending on the device, positioning them as a trustworthy choice for individuals aiming to prevent unwanted pregnancies. For instance, in July 2025, the Society for Family Planning, a US-based professional organization, stated that abortions increased to 1.14 million in 2024, compared with 1.05 million recorded in 2023. Therefore, the surge in unwanted pregnancies is a primary factor fueling the growth of the hormonal intrauterine devices market.
Hormonal Intrauterine Devices (IUDs) Market Segment Analysis: What Are The Core Market Categories?
The hormonal intrauterine devices (iuds) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
Hormonal Intrauterine Devices (IUDs) Market Innovation Trends Shaping Future Development
Major companies in the hormonal intrauterine devices market are focusing on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. Levonorgestrel intrauterine devices (IUDs) are long-term birth control options inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions, providing up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect stems from its capability to increase the density of cervical mucus, thus preventing sperm from reaching the uterus. For heavy bleeding, it functions by thinning the uterine lining, which helps reduce menstrual flow.
Hormonal Intrauterine Devices (IUDs) Market Industry Leaders And Competitive Landscape
Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.
View The Full Hormonal Intrauterine Devices (IUDs) Market Report:
Hormonal Intrauterine Devices (IUDs) Market Regional Analysis And Top Geography
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
